Symbiotec PharmaSymbiotec Pharma

Milestone

Our Journey, since 1995

1995 - 2007

1995 - 1997

1995 : Set up of Laboratory for production of Cortico-Steroids APIs.
1997 : Symbiotec Steroids Private Limited ( SSPL ) formed.

2002 - 2006

2002 : SymbiotecPharmalab Limited incorporated as a private company.
2004 : Set up of Industrial scale Manufacturing Plant at Rau, Indore.
2006 : Expansion of Manufacturing and R&D facilities.

2007

Key Developments :

  • Investments by High Net worth Individuals
  • Commencement of Construction of New large manufacturing facility at SEZ Pithampur, Indore
  • Recognition of R&D unit by   Government of India( (Science & Technology Dept.)

2008 - 2010

2008

Key Developments :

  • EU GMP Certification of RAU Site
  • Set-up R&D Of Biotech (Fermentation) to Strengthen ‘Backward Integration Process’

2009

Key Developments :

  • Successful USFDA inspection of Rau Steroids APIs Plant
  • Start of commercial production of
  1. Steroids (part backward integration process)
  2. Steroid-Hormones APIs
  3. Commencement of construction of Biotech (Fermentation Facility)

2010

Key Developments :

  • First Large contract from one of its key customers.
  • Company  completed process validation of at least 8 hormone APIs

2011 - 2018

2011

Key Developments

  • Commencement of fermentation activities from ‘Biotech Facility at SEZ location’.
  • Infusion of Capital by private equity ‘Franklin Tempelton’

2012

Key Developments

  • Accreditation by US-FDA of SEZ location & Re-accreditation by US –FDA of Rau site
  • Partnered with US based formulation marketing company for Estrogen.

2013 - 2014

2013 – 2014

2013 : Key Developments

Infusion of Capital by private equity ‘Actis’

Eu-GMP Certification / Qualification of Sterile Manufacturing Facility, Rau Site and Eu-GMP Certification of SEZ site.

2014 : Key Developments

Commencement of Production of Phase II Biotech Expansion

Re-Accreditation by US –FDA of Rau Site.

2015-2016:

2015 : Key Developments
Commencement of Large Scale Chemical Synthesis Plant  in June 2015,  with batch size up to 1000 Kg.

Re-Accreditation by US-FDA of SEZ site.

Re-Qualification of  Eu-GMP certification of RAU site  and SEZ site.

2017-2018:

2017 : Key Developments

Re-Accreditation by US –FDA of Rau Site and SEZ site

2018 : Key Developments

Re-Qualification of  Eu-GMP certification of RAU site  and SEZ site.

Infusion of Capital by private equity,  ‘Motilal Oswal Private Equity (MOPE)’ and ‘InvAscent’

HAVE A QUERY ? WE ARE HERE TO HELP